Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An international group of maternal and child population health experts are calling on governments to invest in better obstetric surveillance systems, break down barriers in data sharing, and eradicate a culture of blame to help address stagnating maternal mortality rates globally.

The International Network of Obstetric Survey Systems (INOSS), involving researchers from Oxford Population Health’s National Perinatal Epidemiology Unit (NPEU), outlined these calls to action in a commentary piece published today in The Lancet.

The commentary responds to recent UN data which show that improvements in maternal mortality rates have stalled in 133 countries and are getting worse in 17 countries, particularly in Latin America, the Caribbean, Europe, North America, and sub-Saharan Africa. Women in low- and middle-income countries continue to suffer the greatest burden whilst marginalised groups in high-income countries, such as the United States, are at a disproportionately increased risk.

The commentary calls for three specific actions from governments worldwide:

  1. Investment in the establishment and maintenance of effective and robust enhanced obstetric surveillance systems (EOSS).
  1. Introduction of health-care policies to facilitate and encourage data gathering, linkage, and transfer within existing or newly created legal frameworks.
  1. Implementation of confidential, health-sector-controlled, case-based analyses of maternity care that emphasise learning lessons rather than assigning blame.

Read the full story on the Oxford Population Health website. 

Similar stories

Coal-powered economic growth linked to rising urban air pollution and deaths in India

Research led by the University of Oxford has found that rapid economic growth brought major gains in access to electricity and cleaner cooking in India, but growing reliance on coal-fired power has contributed to worsening outdoor air pollution and a sharp rise in urban air-pollution-related deaths.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Protecting brains and minds in a transition away from fossil fuels

As countries consider how to transition away from fossil fuels, Oxford researchers highlight why mental and brain health must be part of the global health response to climate change, and how health evidence can help shape a fairer, healthier transition.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

University of Oxford announces next-generation AI initiative to detect, assess and respond to pandemics

Oxford researchers are leading an international partnership with the World Health Organization to develop an AI-powered platform designed to help public health authorities detect, assess and respond more rapidly to emerging infectious disease threats.

Japan's role in global health architecture reform

As major donors cut development assistance, Dr Luke Allen reflects on Japan's approach to universal health coverage and a wider shift towards country-led priorities, domestic financing and reform of the global health architecture.

Similar stories

Coal-powered economic growth linked to rising urban air pollution and deaths in India

Research led by the University of Oxford has found that rapid economic growth brought major gains in access to electricity and cleaner cooking in India, but growing reliance on coal-fired power has contributed to worsening outdoor air pollution and a sharp rise in urban air-pollution-related deaths.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Protecting brains and minds in a transition away from fossil fuels

As countries consider how to transition away from fossil fuels, Oxford researchers highlight why mental and brain health must be part of the global health response to climate change, and how health evidence can help shape a fairer, healthier transition.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

University of Oxford announces next-generation AI initiative to detect, assess and respond to pandemics

Oxford researchers are leading an international partnership with the World Health Organization to develop an AI-powered platform designed to help public health authorities detect, assess and respond more rapidly to emerging infectious disease threats.

Japan's role in global health architecture reform

As major donors cut development assistance, Dr Luke Allen reflects on Japan's approach to universal health coverage and a wider shift towards country-led priorities, domestic financing and reform of the global health architecture.